Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: regarding the extension

RE: regarding the extension

posted on Aug 29, 2006 02:53PM
These items were researched for the delayed 3rd quarter 10Q and filed therein. Why would additional time be required to research that which has already been researched and filed as accurate?

During the three months ended February 28, 2006, the balance of outstanding convertible debentures of $748,168 and accrued interest of $112,359, were converted into 22,523,398 shares of the Company`s common stock.

The JV LLC reported net income for the three and nine month periods ended February 28, 2006 of approximately $58,600,000 and $57,200,000, respectively.

http://www.secinfo.com/d12TC3.vFkt.htm

As there have been no outstanding convertible debentures since February 28 and the JV LLC was up to date at the same time, some 6 months has elapsed.

The Company requires additional time in order to adequately analyze appropriate accounting and disclosure matters related to transactions occurring during the quarter.

http://www.secinfo.com/d12TC3.vEGm.htm

Be well

Share
New Message
Please login to post a reply